Wall Street Journal
US · 5 hrs ago
✦ 72✓ Factual
Amgen Drug Gets New Warnings in Japan After Patient Deaths - WSJ
72Quality
0Ratings
0Comments
AI Analysis
Quality 72/100
Partisan intensity 15/100
ObjectivePartisan
Low partisan intensity — consistent with factual reporting✓ Fair headline
An Amgen pharmaceutical product has prompted new warning labels in Japan following reports of patient deaths, according to regulatory action in the Japanese market.
Amgen Drug Gets New Warnings in Japan After Patient Deaths - WSJ
Amgen Drug Gets New Warnings in Japan After Patient Deaths WSJ
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!